Literature DB >> 11236934

Biological features of the clone involved in primary amyloidosis (AL).

V Perfetti1, M C Vignarelli, S Casarini, E Ascari, G Merlini.   

Abstract

Primary light chain-associated amyloidosis (AL) is a plasma cell dyscrasia that causes morbidity via systemic tissue deposition of monoclonal light chains in the form of fibrils (amyloid). It is the most common form of systemic amyloidosis in Western countries and is rapidly fatal. Knowledge of the pathobiology of the underlying B cell clone is of primary importance for the design and optimization of therapeutic strategies.

Entities:  

Mesh:

Year:  2001        PMID: 11236934     DOI: 10.1038/sj.leu.2402015

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  2 in total

1.  A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.

Authors:  C P Venner; J D Gillmore; S Sachchithanantham; S Mahmood; T Lane; D Foard; L Rannigan; S D J Gibbs; J H Pinney; C J Whelan; H J Lachmann; P N Hawkins; A D Wechalekar
Journal:  Leukemia       Date:  2014-07-16       Impact factor: 11.528

2.  Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis.

Authors:  V Perfetti; A M Coluccia; D Intini; U Malgeri; M C Vignarelli; S Casarini; G Merlini; A Neri
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.